Montbriand J R, Appelman H D, Cotner E K, Nostrant T T, Elta G H
Department of Internal Medicine, University of Michigan, Ann Arbor.
Am J Gastroenterol. 1989 Dec;84(12):1513-6.
The effect of treatment of Campylobacter pylori-associated gastritis on acid secretion was studied to examine further the strong association between C. pylori and peptic diseases. Twelve symptomatic patients with non-ulcer dyspepsia and C. pylori-associated histologic gastritis had basal and pentagastrin-stimulated gastric acid analysis before and after a 14-day course of amoxicillin 250 mg qid and bismuth subsalicylate 524 mg qid. Endoscopy, antral biopsies, and symptom questionnaires were obtained at entry and at the conclusion of the study. C. pylori was identified by Warthin-Starry stain. Biopsy specimens were also graded for the severity of chronic inflammation and the presence of neutrophils in the epithelium. The treatment regimen cleared C. pylori in 10 of 12 patients. Dyspeptic symptoms improved in 10 of 12 patients, two of whom did not clear the organism, and were unchanged in the remaining two patients, both of whom cleared the bacteria. Neutrophil infiltration in the antral biopsies resolved in 10 patients, including nine with C. pylori clearance and one with persistence of the organism. The severity of the underlying chronic inflammation improved in only one of the 10 organism-free patients and one of the two persistently infected individuals. Pretreatment gastric acid analysis demonstrated hypochlorhydria in three of 12 patients, mild hyperchlorhydria in three of 12 patients, mild hyperchlorhydria in two of 12, and normal acid secretion in the remaining seven patients. Posttreatment acid studies revealed that four of 12 patients were hypochlorhydric, one of 12 had hyperchlorhydria, and seven of 12 were normochlorhydric. After treatment, there was no significant change in basal or maximal acid secretion in the 10 patients who cleared the organism. The two patients who failed to clear C. pylori had insignificant increases in acid secretion after treatment. Our data show no consistent pretreatment pattern of acid secretion in patients with C. pylori-associated gastritis. In addition, gastric acid output did not show a consistent change after treatment for C. pylori. This suggests that the association between C. pylori infection and peptic diseases does not occur via altered acid secretion.
为进一步研究幽门螺杆菌(Campylobacter pylori)与消化性疾病之间的紧密关联,我们对幽门螺杆菌相关性胃炎的治疗对胃酸分泌的影响进行了研究。12例有症状的非溃疡性消化不良且患有幽门螺杆菌相关性组织学胃炎的患者,在接受为期14天的阿莫西林250毫克每日4次和次水杨酸铋524毫克每日4次的治疗疗程前后,进行了基础胃酸分泌及五肽胃泌素刺激的胃酸分泌分析。在研究开始时和结束时进行了内镜检查、胃窦活检及症状问卷调查。通过Warthin-Starry染色鉴定幽门螺杆菌。活检标本还根据慢性炎症的严重程度及上皮细胞中中性粒细胞的存在情况进行分级。治疗方案使12例患者中的10例清除了幽门螺杆菌。12例患者中有10例的消化不良症状得到改善,其中2例未清除该病原体,另外2例症状未改变,这2例患者均清除了细菌。胃窦活检中的中性粒细胞浸润在10例患者中消失,其中9例幽门螺杆菌被清除,1例病原体持续存在。在10例无病原体的患者中只有1例以及2例持续感染的患者中的1例,其潜在慢性炎症的严重程度有所改善。治疗前的胃酸分析显示,12例患者中有3例胃酸过少,3例轻度胃酸过多,2例轻度胃酸过多,其余7例患者胃酸分泌正常。治疗后的胃酸研究显示,12例患者中有4例胃酸过少,1例胃酸过多,7例胃酸分泌正常。治疗后,10例清除病原体的患者的基础胃酸分泌或最大胃酸分泌没有显著变化。2例未清除幽门螺杆菌的患者治疗后胃酸分泌有不显著的增加。我们的数据显示,幽门螺杆菌相关性胃炎患者治疗前的胃酸分泌模式并不一致。此外,幽门螺杆菌治疗后胃酸分泌量也没有呈现出一致的变化。这表明幽门螺杆菌感染与消化性疾病之间的关联并非通过胃酸分泌改变而发生。